Nick Boyle’s promising rookie season with the Baltimore Ravens was abruptly interrupted by a performance-enhancing drug violation. After being selected in the fifth round of the 2015 NFL Draft, Boyle emerged as a useful blocker and receiver in Baltimore’s offense, starting games and contributing 18 receptions for 153 yards through 11 appearances. On December 7, 2015, the NFL announced that he had violated the league’s performance-enhancing drug policy. Boyle was immediately suspended for the final four games of the season—Weeks 14 through 17—and forfeited $112,132 in salary. The suspension was especially damaging because he was still establishing himself in a crowded tight-end group that included Maxx Williams, Crockett Gillmore, Dennis Pitta, and Konrad Reuland.
The episode became substantially more serious when Boyle was suspended again on February 19, 2016, this time for the first ten games of the upcoming season because of a second violation of the NFL’s performance-enhancing drug policy. The repeat offense cost him most of the 2016 campaign and kept him away from the Ravens until he was activated before Week 12 on November 26. He returned to make six appearances and record six receptions for 44 yards, but the lost development time threatened to derail his career. Boyle ultimately rebuilt his reputation through his blocking, special-teams work, and durability, later becoming a respected starter and signing lucrative extensions with Baltimore. The available account confirms the two violations and their suspensions, but does not identify the substance involved or allege a broader doping network.
Follow the sources
Status and citations are supplied by the archive. AI concept art is an interpretation, not historical evidence.